加载中...

点击这里给我发消息

QQ群:417857029

新产品·新技术信息

研究者开发出新型用于治疗眼角膜的粘合剂

来源:specialchem2020年07月10日

阅读次数:

  Researchers from Maisonneuve-Rosemont Hospital Research Center (HMR) have developed LiQD Cornea for treating corneal ulcers and corneal perforations without transplantation.
  
  LiQD Cornea is a synthetic and biocompatible adhesive liquid hydrogel, that gels in the corneal tissues, promotes tissue regeneration and treats corneal perforations without the need for transplantation.
  
  Effective and Accessible Solution without Transplantation
  
  “Our work made it possible to find an effective and accessible solution, to treat corneal perforations,” said May Griffith, director of the corneal regeneration by biomaterials unit of HMR.
  
  "Until now, the perforated corneas of patients on standby have been sealed with a medical-grade super glue, but which is only a short-term solution, as it is poorly tolerated in the eye, thus making transplantation necessary", added Griffith.
  
  LiQD Cornea is crucial for patients who cannot undergo corneal transplantation due to a global shortage of donor corneas. The solution has been discovered by a consortium of researchers and clinicians from Europe, Oceania and America under the direction of May Griffith.
  • 标签:
相关阅读

本站所有信息与内容,版权归原作者所有。网站中部分新闻、文章来源于网络或会员供稿,如读者对作品版权有疑议,请及时与我们联系,电话:025-85303363 QQ:2402955403。文章仅代表作者本人的观点,与本网站立场无关。转载本站的内容,请务必注明"来源:林中祥胶粘剂技术信息网(www.adhesive-lin.com)".

网友评论

©2015 南京爱德福信息科技有限公司   苏ICP备10201337 | 技术支持:建站100

客服

客服
电话

1

手机:18114925746

客服
邮箱

565052751@qq.com

若您需要帮助,您也可以留下联系方式

发送邮箱

扫二
维码

微信二维码